Researchers Develop Blood Test That May Detect Testicular Cancer Missed by Standard Markers
Mayo Clinic researchers have developed a blood test that detected 93% of germ cell tumors—including cases missed by standard markers.
Mayo Clinic researchers have developed a blood test that detected 93% of germ cell tumors—including cases missed by standard markers.
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.
Beckman Coulter Diagnostics' DxC 500i Clinical Analyzer has received FDA 510(k) clearance, improving networking capabilities.
EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG), is validated for DBS samples, to enhance measles diagnosis and immunity assessment.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...